June 11, 2015
Abstract on MOZArT (Management of Osteoarthritis of the Knee with Zeel® And Traumeel® Injections) published in the prestigious EULAR journal “Annals of the Rheumatic Diseases”
At the EULAR (Europ. League against Rheumatism) 2015 congress in Rome an abstract of the MOZArT study was published in the EULAR journal “Annals of the Rheumatic Diseases”.
The MOZArT study is a multi-center, double-blind, randomized placebo-controlled trial showing that combined intra-articular injections of Traumeel® and Zeel® T are an effective and safe first line injection treatment that reduces pain of osteoarthritis of the knee by more than 60% and has a comparable effect size to existing therapies.
Link to MOZArT osteoarthritis trial abstract